1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Organ and Tissues Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Artificial Kidney
1.2.3 Artificial Heart & Ventricular Assist Device
1.2.4 Cochlear Implant
1.2.5 Artificial Lung
1.2.6 Artificial Liver
1.2.7 Artificial Pancreas
1.2.8 Bionic Hands & Prosthetics
1.2.9 Others
1.3 Market by Application
1.3.1 Global Artificial Organ and Tissues Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical Use
1.3.3 Clinical Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Organ and Tissues Market Perspective (2018-2029)
2.2 Artificial Organ and Tissues Growth Trends by Region
2.2.1 Global Artificial Organ and Tissues Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Organ and Tissues Historic Market Size by Region (2018-2023)
2.2.3 Artificial Organ and Tissues Forecasted Market Size by Region (2024-2029)
2.3 Artificial Organ and Tissues Market Dynamics
2.3.1 Artificial Organ and Tissues Industry Trends
2.3.2 Artificial Organ and Tissues Market Drivers
2.3.3 Artificial Organ and Tissues Market Challenges
2.3.4 Artificial Organ and Tissues Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Organ and Tissues Players by Revenue
3.1.1 Global Top Artificial Organ and Tissues Players by Revenue (2018-2023)
3.1.2 Global Artificial Organ and Tissues Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Organ and Tissues Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Organ and Tissues Revenue
3.4 Global Artificial Organ and Tissues Market Concentration Ratio
3.4.1 Global Artificial Organ and Tissues Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Organ and Tissues Revenue in 2022
3.5 Artificial Organ and Tissues Key Players Head office and Area Served
3.6 Key Players Artificial Organ and Tissues Product Solution and Service
3.7 Date of Enter into Artificial Organ and Tissues Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Organ and Tissues Breakdown Data by Type
4.1 Global Artificial Organ and Tissues Historic Market Size by Type (2018-2023)
4.2 Global Artificial Organ and Tissues Forecasted Market Size by Type (2024-2029)
5 Artificial Organ and Tissues Breakdown Data by Application
5.1 Global Artificial Organ and Tissues Historic Market Size by Application (2018-2023)
5.2 Global Artificial Organ and Tissues Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Organ and Tissues Market Size (2018-2029)
6.2 North America Artificial Organ and Tissues Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Organ and Tissues Market Size by Country (2018-2023)
6.4 North America Artificial Organ and Tissues Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Organ and Tissues Market Size (2018-2029)
7.2 Europe Artificial Organ and Tissues Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Organ and Tissues Market Size by Country (2018-2023)
7.4 Europe Artificial Organ and Tissues Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Organ and Tissues Market Size (2018-2029)
8.2 Asia-Pacific Artificial Organ and Tissues Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Organ and Tissues Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Organ and Tissues Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Organ and Tissues Market Size (2018-2029)
9.2 Latin America Artificial Organ and Tissues Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Organ and Tissues Market Size by Country (2018-2023)
9.4 Latin America Artificial Organ and Tissues Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Organ and Tissues Market Size (2018-2029)
10.2 Middle East & Africa Artificial Organ and Tissues Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Organ and Tissues Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Organ and Tissues Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius Medical Care
11.1.1 Fresenius Medical Care Company Detail
11.1.2 Fresenius Medical Care Business Overview
11.1.3 Fresenius Medical Care Artificial Organ and Tissues Introduction
11.1.4 Fresenius Medical Care Revenue in Artificial Organ and Tissues Business (2018-2023)
11.1.5 Fresenius Medical Care Recent Development
11.2 Cochlear
11.2.1 Cochlear Company Detail
11.2.2 Cochlear Business Overview
11.2.3 Cochlear Artificial Organ and Tissues Introduction
11.2.4 Cochlear Revenue in Artificial Organ and Tissues Business (2018-2023)
11.2.5 Cochlear Recent Development
11.3 Abiomed
11.3.1 Abiomed Company Detail
11.3.2 Abiomed Business Overview
11.3.3 Abiomed Artificial Organ and Tissues Introduction
11.3.4 Abiomed Revenue in Artificial Organ and Tissues Business (2018-2023)
11.3.5 Abiomed Recent Development
11.4 ABBOTT
11.4.1 ABBOTT Company Detail
11.4.2 ABBOTT Business Overview
11.4.3 ABBOTT Artificial Organ and Tissues Introduction
11.4.4 ABBOTT Revenue in Artificial Organ and Tissues Business (2018-2023)
11.4.5 ABBOTT Recent Development
11.5 Baxter
11.5.1 Baxter Company Detail
11.5.2 Baxter Business Overview
11.5.3 Baxter Artificial Organ and Tissues Introduction
11.5.4 Baxter Revenue in Artificial Organ and Tissues Business (2018-2023)
11.5.5 Baxter Recent Development
11.6 B.Braun
11.6.1 B.Braun Company Detail
11.6.2 B.Braun Business Overview
11.6.3 B.Braun Artificial Organ and Tissues Introduction
11.6.4 B.Braun Revenue in Artificial Organ and Tissues Business (2018-2023)
11.6.5 B.Braun Recent Development
11.7 Asahi Kasei Corporation
11.7.1 Asahi Kasei Corporation Company Detail
11.7.2 Asahi Kasei Corporation Business Overview
11.7.3 Asahi Kasei Corporation Artificial Organ and Tissues Introduction
11.7.4 Asahi Kasei Corporation Revenue in Artificial Organ and Tissues Business (2018-2023)
11.7.5 Asahi Kasei Corporation Recent Development
11.8 Nipro
11.8.1 Nipro Company Detail
11.8.2 Nipro Business Overview
11.8.3 Nipro Artificial Organ and Tissues Introduction
11.8.4 Nipro Revenue in Artificial Organ and Tissues Business (2018-2023)
11.8.5 Nipro Recent Development
11.9 MED-EL
11.9.1 MED-EL Company Detail
11.9.2 MED-EL Business Overview
11.9.3 MED-EL Artificial Organ and Tissues Introduction
11.9.4 MED-EL Revenue in Artificial Organ and Tissues Business (2018-2023)
11.9.5 MED-EL Recent Development
11.10 Toray Medical
11.10.1 Toray Medical Company Detail
11.10.2 Toray Medical Business Overview
11.10.3 Toray Medical Artificial Organ and Tissues Introduction
11.10.4 Toray Medical Revenue in Artificial Organ and Tissues Business (2018-2023)
11.10.5 Toray Medical Recent Development
11.11 Sonova
11.11.1 Sonova Company Detail
11.11.2 Sonova Business Overview
11.11.3 Sonova Artificial Organ and Tissues Introduction
11.11.4 Sonova Revenue in Artificial Organ and Tissues Business (2018-2023)
11.11.5 Sonova Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Detail
11.12.2 Medtronic Business Overview
11.12.3 Medtronic Artificial Organ and Tissues Introduction
11.12.4 Medtronic Revenue in Artificial Organ and Tissues Business (2018-2023)
11.12.5 Medtronic Recent Development
11.13 Getinge (Maquet)
11.13.1 Getinge (Maquet) Company Detail
11.13.2 Getinge (Maquet) Business Overview
11.13.3 Getinge (Maquet) Artificial Organ and Tissues Introduction
11.13.4 Getinge (Maquet) Revenue in Artificial Organ and Tissues Business (2018-2023)
11.13.5 Getinge (Maquet) Recent Development
11.14 William Demant
11.14.1 William Demant Company Detail
11.14.2 William Demant Business Overview
11.14.3 William Demant Artificial Organ and Tissues Introduction
11.14.4 William Demant Revenue in Artificial Organ and Tissues Business (2018-2023)
11.14.5 William Demant Recent Development
11.15 LivaNova (Sorin)
11.15.1 LivaNova (Sorin) Company Detail
11.15.2 LivaNova (Sorin) Business Overview
11.15.3 LivaNova (Sorin) Artificial Organ and Tissues Introduction
11.15.4 LivaNova (Sorin) Revenue in Artificial Organ and Tissues Business (2018-2023)
11.15.5 LivaNova (Sorin) Recent Development
11.16 Terumo
11.16.1 Terumo Company Detail
11.16.2 Terumo Business Overview
11.16.3 Terumo Artificial Organ and Tissues Introduction
11.16.4 Terumo Revenue in Artificial Organ and Tissues Business (2018-2023)
11.16.5 Terumo Recent Development
11.17 Hangzhou Nurotron
11.17.1 Hangzhou Nurotron Company Detail
11.17.2 Hangzhou Nurotron Business Overview
11.17.3 Hangzhou Nurotron Artificial Organ and Tissues Introduction
11.17.4 Hangzhou Nurotron Revenue in Artificial Organ and Tissues Business (2018-2023)
11.17.5 Hangzhou Nurotron Recent Development
11.18 Syncardia
11.18.1 Syncardia Company Detail
11.18.2 Syncardia Business Overview
11.18.3 Syncardia Artificial Organ and Tissues Introduction
11.18.4 Syncardia Revenue in Artificial Organ and Tissues Business (2018-2023)
11.18.5 Syncardia Recent Development
11.19 CorWave
11.19.1 CorWave Company Detail
11.19.2 CorWave Business Overview
11.19.3 CorWave Artificial Organ and Tissues Introduction
11.19.4 CorWave Revenue in Artificial Organ and Tissues Business (2018-2023)
11.19.5 CorWave Recent Development
11.20 Listent Medical
11.20.1 Listent Medical Company Detail
11.20.2 Listent Medical Business Overview
11.20.3 Listent Medical Artificial Organ and Tissues Introduction
11.20.4 Listent Medical Revenue in Artificial Organ and Tissues Business (2018-2023)
11.20.5 Listent Medical Recent Development
11.21 Evaheart
11.21.1 Evaheart Company Detail
11.21.2 Evaheart Business Overview
11.21.3 Evaheart Artificial Organ and Tissues Introduction
11.21.4 Evaheart Revenue in Artificial Organ and Tissues Business (2018-2023)
11.21.5 Evaheart Recent Development
11.22 Open Bionics
11.22.1 Open Bionics Company Detail
11.22.2 Open Bionics Business Overview
11.22.3 Open Bionics Artificial Organ and Tissues Introduction
11.22.4 Open Bionics Revenue in Artificial Organ and Tissues Business (2018-2023)
11.22.5 Open Bionics Recent Development
11.23 OYMotion Technologies
11.23.1 OYMotion Technologies Company Detail
11.23.2 OYMotion Technologies Business Overview
11.23.3 OYMotion Technologies Artificial Organ and Tissues Introduction
11.23.4 OYMotion Technologies Revenue in Artificial Organ and Tissues Business (2018-2023)
11.23.5 OYMotion Technologies Recent Development
11.24 Mobius Bionics
11.24.1 Mobius Bionics Company Detail
11.24.2 Mobius Bionics Business Overview
11.24.3 Mobius Bionics Artificial Organ and Tissues Introduction
11.24.4 Mobius Bionics Revenue in Artificial Organ and Tissues Business (2018-2023)
11.24.5 Mobius Bionics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
| ※参考情報 人工臓器と組織は、医療における革新的な技術の一つであり、患者の生活の質を向上させるための重要な役割を果たしています。これらは、生体の臓器や組織の機能を模倣または補完するために設計されており、様々な病気や傷害に対する治療手段として広く用いられています。 まず、人工臓器の定義について触れます。人工臓器とは、自然の臓器の機能を模倣し、医療的な目的で設計されたデバイスです。これには、完全に人工的に作られた臓器や、動物由来の組織を使用したものも含まれます。人工臓器は、特に臓器移植の需要が高まり、供給が追いつかない現代において、重要な代替手段となっています。 人工臓器の主な特徴は、体内に埋め込むことができる、もしくは体外で操作できる点にあります。これにより、患者の状態や病状に応じた柔軟な治療が可能になります。また、人工臓器は、機械的な部分と生体材料とを組み合わせた構造を持つことが多く、いわゆる「ハイブリッド型」と呼ばれるものが増えています。これにより、生体適合性や機能性を高め、身体との相互作用を最適化することが目指されています。 人工臓器には、さまざまな種類があります。最も一般的なものには、人工心臓、人工腎臓、人工膵臓、人工肝臓などがあります。人工心臓は、心臓病や心不全の患者に対して心臓の機能を補完することを目的としています。人工腎臓は、腎不全の患者に対する治療手段として、血液をろ過する役割を担っています。人工膵臓は、糖尿病患者のインスリン分泌を代替するために使用され、人工肝臓は、肝機能障害の治療に寄与します。 次に、人工組織についてですが、こちらも生体の組織を模倣または再生することを目的として設計されています。人工組織は、例えば皮膚、骨、軟骨など、さまざまなタイプの組織が含まれます。人工皮膚は、火傷や外傷を負った患者の治療に使われ、新しい皮膚の成長を助ける目的で設計されています。人工骨や軟骨は、骨折や関節疾患の治療に利用されています。 これらの人工臓器や組織は、再生医療や組織工学と密接に関連しており、再生医療の分野では自分自身の細胞を用いて人工組織や臓器を作成することが試みられています。この技術は、患者の免疫拒絶反応を防ぐ上で非常に重要です。患者自身の細胞を使うことで、より高い可能性で身体に適合する材料を得ることができ、拒絶反応のリスクを低減できます。 人工臓器や組織の製造には、さまざまな先端技術が用いられています。一例として、3Dプリンティング技術が挙げられます。この技術は、生体材料を使用して、複雑な形状の組織や臓器を精密に作成することを可能にします。3Dプリンティングによって、個々の患者に最適化されたデバイスを提供することができ、医療のパーソナライズ化が進む可能性があります。 さらに、ナノテクノロジーも人工臓器や組織の開発において重要な役割を果たしています。ナノテクノロジーを活用することで、細胞や組織の機能を改良したり、治療効果を高めたりすることができます。これにより、より効果的な人工臓器や敷居が生まれることが期待されています。 人工臓器や組織の臨床応用も進展しています。特に、心臓病や腎不全、糖尿病など、慢性疾患を抱える患者に対しては、これまで以上に多くの選択肢が提供されるようになっています。また、人工臓器や組織の研究開発は、医療の現場での期待される効果や利点を踏まえつつ、倫理的な問題や費用対効果を考慮して進められています。 最後に、将来的な展望について考えます。人工臓器や組織の技術は、今後ますます洗練され、多様化していくでしょう。特に再生医療の進展によって、自身の細胞を用いた治療法が普及し、患者にとってより良い結果をもたらすことが期待されます。また、持続可能な材料や生体に優しい技術の導入によって、環境への配慮も進んでいくはずです。医療の未来において、人工臓器や組織の役割はますます大きくなると考えられます。 このように、人工臓器と組織は現代医療において重要な位置を占めており、その研究や開発は今後も続けられるでしょう。私たちが直面する多くの医療課題に対して、これらの技術が新たな解決策を提供することを期待しています。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
